Metabolism - New Therapeutic Targets for Inflammatory Bowel Disease

被引:0
|
作者
Kaser, Arthur [1 ,2 ]
机构
[1] Univ Cambridge, Cambridge Inst Therapeut Immunol & Infect Dis, Puddicombe Way, Cambridge CB2 0AW, England
[2] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Puddicombe Way, Cambridge CB2 0AW, England
关键词
FAMIN;
D O I
10.1055/a-1606-5527
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:S11 / S12
页数:2
相关论文
共 50 条
  • [41] Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across? Reply
    D'Haens, Geert
    Vermeire, Severine
    Laharie, David
    GASTROENTEROLOGY, 2018, 155 (04) : 1278 - 1279
  • [42] Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise
    Trivedi, Palak J.
    Adams, David H.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S641 - S652
  • [43] Treatment targets in inflammatory bowel disease
    Sellin, J
    ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (02) : 217 - 218
  • [44] HYDROGEL TARGETS INFLAMMATORY BOWEL DISEASE
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (32) : 49 - 49
  • [45] NEW THERAPEUTIC AGENTS IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    GEIER, DL
    MINER, PB
    AMERICAN JOURNAL OF MEDICINE, 1992, 93 (02): : 199 - 208
  • [46] Therapeutic options for patients with inflammatory bowel disease: New steroids
    Brynskov, J
    DRUGS OF TODAY, 1997, 33 (02) : 131 - 138
  • [47] New and current Therapeutic Goals of chronic inflammatory Bowel Disease
    Lande, Raul
    Blumenstein, Irina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2025, 150 (08) : 427 - 432
  • [48] New Therapeutic Strategies in chronic-inflammatory Bowel Disease
    Kucharzik, Torsten
    Maaser, Christian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (03) : 194 - 197
  • [49] Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: Future therapeutic targets
    Kraneveld, Aletta D.
    Rijnierse, Anneke
    Nijkamp, Frans P.
    Garssen, Johan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 585 (2-3) : 361 - 374
  • [50] Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
    Peyrin-Biroulet, L.
    Sandborn, W.
    Sands, B. E.
    Reinisch, W.
    Bemelman, W.
    Bryant, R. V.
    D'Haens, G.
    Dotan, I.
    Dubinsky, M.
    Feagan, B.
    Fiorino, G.
    Gearry, R.
    Krishnareddy, S.
    Lakatos, P. L.
    Loftus, E. V., Jr.
    Marteau, P.
    Munkholm, P.
    Murdoch, T. B.
    Ordas, I.
    Panaccione, R.
    Riddell, R. H.
    Ruel, J.
    Rubin, D. T.
    Samaan, M.
    Siegel, C. A.
    Silverberg, M. S.
    Stoker, J.
    Schreiber, S.
    Travis, S.
    Van Assche, G.
    Danese, S.
    Panes, J.
    Bouguen, G.
    O'Donnell, S.
    Pariente, B.
    Winer, S.
    Hanauer, S.
    Colombel, J. -F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (09): : 1324 - 1338